Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration

104Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

Abstract

Human pluripotent stem cells (hPSCs), including both embryonic and induced pluripotent stem cells, possess the unique ability to readily differentiate into any cell type of the body, including cells of the retina. Although previous studies have demonstrated the ability to differentiate hPSCs to a retinal lineage, the ability to derive retinal ganglion cells (RGCs) from hPSCs has been complicated by the lack of specific markers with which to identify these cells from a pluripotent source. In the current study, the definitive identification of hPSC-derived RGCs was accomplished by their directed, stepwise differentiation through an enriched retinal progenitor intermediary, with resultant RGCs expressing a full complement of associated features and proper functional characteristics. These results served as the basis for the establishment of induced pluripotent stem cells (iPSCs) from a patient with a genetically inherited form of glaucoma, which results in damage and loss of RGCs. Patient-derived RGCs specifically exhibited a dramatic increase in apoptosis, similar to the targeted loss of RGCs in glaucoma, which was significantly rescued by the addition of candidate neuroprotective factors. Thus, the current study serves to establish a method by which to definitively acquire and identify RGCs from hPSCs and demonstrates the ability of hPSCs to serve as an effective in vitro model of disease progression. Moreover, iPSC-derived RGCs can be utilized for future drug screening approaches to identify targets for the treatment of glaucoma and other optic neuropathies.

References Powered by Scopus

Embryonic stem cell lines derived from human blastocysts

13256Citations
N/AReaders
Get full text

Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis

5122Citations
N/AReaders
Get full text

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA

2196Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Regenerating Eye Tissues to Preserve and Restore Vision

132Citations
N/AReaders
Get full text

Organoid technology for retinal repair

123Citations
N/AReaders
Get full text

Three-Dimensional Retinal Organoids Facilitate the Investigation of Retinal Ganglion Cell Development, Organization and Neurite Outgrowth from Human Pluripotent Stem Cells

121Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ohlemacher, S. K., Sridhar, A., Xiao, Y., Hochstetler, A. E., Sarfarazi, M., Cummins, T. R., & Meyer, J. S. (2016). Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration. Stem Cells, 34(6), 1553–1562. https://doi.org/10.1002/stem.2356

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 35

63%

Researcher 15

27%

Professor / Associate Prof. 5

9%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 23

37%

Agricultural and Biological Sciences 17

27%

Neuroscience 16

25%

Medicine and Dentistry 7

11%

Article Metrics

Tooltip
Mentions
News Mentions: 3
References: 1
Social Media
Shares, Likes & Comments: 3

Save time finding and organizing research with Mendeley

Sign up for free